Results 91 to 100 of about 79,054 (352)

Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference [PDF]

, 2019
Mark Stacy, Martha Sajatovic, John M. Kane, Andrew J. Cutler, Grace Liang, Christopher O’Brien, Christoph U. Correll   +6 more
openalex   +1 more source

NBI‐98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double‐blind, placebo‐controlled study

Movement Disorders, 2015
Tardive dyskinesia is a persistent movement disorder induced by chronic neuroleptic exposure. NBI‐98854 is a novel, highly selective, vesicular monoamine transporter 2 inhibitor.
Christopher F. O’Brien, R. Jimenez, R. Hauser, S. Factor, Joshua Burke, Daniel Mandri, Julio C. Castro‐Gayol   +6 more
semanticscholar   +1 more source

Ethnic and Gender Disparities in Access to Deep Brain Stimulation Surgery for Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Deep brain stimulation (DBS) is an established treatment for Parkinson's disease (PD) in appropriately selected patients. DBS may be underused in certain patient populations, especially women and racialized groups. Barriers and biases to receiving DBS that could account for underuse among these groups are not well studied in Canada.
Fang Ba, Sabrina Poonja, Pouria Torabi, Kevin Yen, Bashir Daud Shah, Eric Noyes, Gail Dimapilis, Shaina Corrick, Tejas Sankar, Alex Rajput, Oury Monchi, Aleksander M. Vitali, Bukola Salami, Aakash Shetty, Janis M. Miyasaki   +14 more
wiley   +1 more source

Adipokines, Vitamin D, and Selected Inflammatory Biomarkers among Parkinson’s Disease Patients with and without Dyskinesia: A Preliminary Examination

Metabolites
Parkinson’s disease (PD), a widely recognized neurodegenerative disorder, is characterized by a spectrum of symptoms including motor fluctuations and dyskinesia.
Jan Milanowski, Jarosław Nuszkiewicz, Beata Lisewska, Paweł Lisewski, Karolina Szewczyk-Golec   +4 more
doaj   +1 more source

An effective combination of whole-exome sequencing and runs of homozygosity for the diagnosis of primary ciliary dyskinesia in consanguineous families [PDF]

, 2017
Ting Guo, Zhiping Tan, Hua-Mei Chen, Zheng Dong-yuan, Lv Liu, Xingang Huang, Ping Chen, Hong Luo, Yifeng Yang   +8 more
openalex   +1 more source

The Feasibility and Practical Utility of Virtual Visits for Patients with Parkinson's Disease in Different World Regions

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Overcoming existing access barriers is crucial for better‐specialized health care of patients with Parkinson's disease (PD). Objective The aim of the study was to compare the access and visit quality/acceptability between in‐office and virtual telemedicine visits.
Álvaro García‐Bustillo, Jinyoung Youn, Jong Hyeon Ahn, Oluwadamilola Ojo, Njideka Okubadejo, Zakiyah Aldaajani, Mohamed Essam, Ali Shalash, Adriana Cardozo, Meredith Spindler, Zoltan Mari, Esther Cubo   +11 more
wiley   +1 more source

Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder

Frontiers in Pharmacology, 2017
Guanosine (GUO) is a guanine-based purine nucleoside with important trophic functions and promising neuroprotective properties. Although the neuroprotective effects of GUO have been corroborated in cellular models of Parkinson’s disease (PD), its ...
Caio M. Massari, Marc López-Cano, Marc López-Cano, Fabiana Núñez, Fabiana Núñez, Víctor Fernández-Dueñas, Víctor Fernández-Dueñas, Carla I. Tasca, Carla I. Tasca, Francisco Ciruela, Francisco Ciruela   +10 more
doaj   +1 more source

Primary ciliary dyskinesia in the genomics age.

The Lancet Respiratory Medicine, 2020
J. Lucas, S. Davis, H. Omran, A. Shoemark   +3 more
semanticscholar   +1 more source

Safinamide in the management of patients with Parkinson’s disease not stabilized on levodopa: a review of the current clinical evidence

Therapeutics and Clinical Risk Management, 2018
Sagari Bette, Danielle S Shpiner, Carlos Singer, Henry Moore Department of Neurology, Division of Parkinson’s Disease and Movement Disorders, University of Miami – Miller School of Medicine, Miami, FL, USA Abstract: Safinamide (Xadago®)
Bette S, Shpiner DS, Singer C, Moore H
doaj  

The effect of dyskinesia on postural control, balance, gait, and fall risk in people with Parkinson’s disease: a systematic review protocol

Geriatrics, Gerontology and Aging
Dyskinesia affects the limbs, trunk, and head and is more prevalent in people with Parkinson’s disease (PD) and a history of falls. More evidence about the effects of dyskinesia on postural control, balance, gait, and fall risk could help improve the ...
Lucas Henrique Caetano Carmona dos Santos, Sandra Maria Sbeghen Ferreira de Freitas, Rafaela Barroso de Souza Costa Garbus, Tiago Henrique Garcia da Silva, Kirsty McDonald, Jane Alty, Mark Dominic Latt, Paulo Henrique Silva Pelicioni   +7 more
doaj   +1 more source